Novo Nordisk’s chief executive, Mike Doustdar, is a year into a corporate turnaround. He says investors are still underestimating the promise of the company’s drugs.
Business
·
Ozempic Maker Novo Nordisk’s Investors Are Nervously Looking Into the Future
CN
CitrixNews Staff
Originally reported by New York Times. Read the full story at the original source.
Related Articles
Business
Life is too expensive for too many - PM says
Life is too expensive for too many - PM saysTo play this video you need to enable JavaScript in your browser.This video ...
CitrixNews Staff
·
1 hour ago
Business
'We can make this next decade better than the last'
'We can make this next decade better than the last'To play this video you need to enable JavaScript in your br...
CitrixNews Staff
·
1 hour ago
Business
How to get a refund when using your credit card
How to get a refund when using your credit cardTo play this video you need to enable JavaScript in your browser.This vid...
CitrixNews Staff
·
1 hour ago
Business
‘Not perfectly aligned’ with human values: Anthropic admits security failures behind AI hacking incidents
Anthropic said it had found defective training set-ups in its models. Photograph: David Talukdar/ShutterstockView image...
CitrixNews Staff
·
1 hour ago